Drug Approval | October 05, 2022
Lupin receives approval from USFDA for Darunavir Tablets
The product will be manufactured at Lupin's facility in Nagpur, India.
The product will be manufactured at Lupin's facility in Nagpur, India.
The companies will leverage their respective proprietary technology platforms
Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. FDA
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by MBR
Lupin is the 6th largest company in the Indian Pharmaceutical Market
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
Subscribe To Our Newsletter & Stay Updated
